Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Protalix Biotherapeutics Inc (NYSE American:PLX)

0.613
Delayed Data
As of Dec 15
 -0.0057 / -0.92%
Today’s Change
0.28
Today|||52-Week Range
1.51
+37.75%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues2.1M2.9M6.4M7.5M
 
 
 
 
 
Cost of Goods Sold1.5M1.6M5.0M5.6M
 
 
 
 
 
Depreciation And Amortization494.0K492.0K494.0K483.0K
 
 
 
 
 
 
Operating ExpensesGross Income129.0K801.0K835.0K1.5M
 
 
 
 
 
General Expenses14.7M8.5M12.1M10.0M
 
 
 
 
 
Research And Development11.5M6.0M9.3M7.1M
 
 
 
 
 
Total Operating Expenses16.6M10.6M17.6M16.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.5M-7.7M-11.3M-8.5M
 
 
 
 
 
Extraordinary Credit14.1M0.0014.3M0.00
 
 
 
Extraordinary Charge0.00-52.3M0.00-1.3M
 
 
 
Interest Expense On Debt8.0M2.1M3.0M2.4M
 
 
 
 
 
Other Expenses5.8M1.3M478.0K729.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.6M-59.1M450.0K-11.4M
 
 
 
 
 
Net Income-2.6M-59.1M450.0K-11.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS124.1M124.5M127.5M132.5M
 
 
 
 
 
Shares To Calculate EPS Diluted124.1M124.5M192.6M132.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.48-$0.06-$0.09
 
 
 
 
 
EPS Diluted-$0.02-$0.48-$0.06-$0.09